Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Interest & Investment Income (2016 - 2022)

Historic Interest & Investment Income for Abeona Therapeutics (ABEO) over the last 12 years, with Q2 2022 value amounting to $30000.0.

  • Abeona Therapeutics' Interest & Investment Income rose 27500.0% to $30000.0 in Q2 2022 from the same period last year, while for Jun 2022 it was $77000.0, marking a year-over-year decrease of 8079.8%. This contributed to the annual value of $69000.0 for FY2021, which is 9469.64% down from last year.
  • According to the latest figures from Q2 2022, Abeona Therapeutics' Interest & Investment Income is $30000.0, which was up 27500.0% from $1000.0 recorded in Q1 2022.
  • In the past 5 years, Abeona Therapeutics' Interest & Investment Income ranged from a high of $652000.0 in Q1 2020 and a low of $1000.0 during Q1 2022
  • Over the past 5 years, Abeona Therapeutics' median Interest & Investment Income value was $104000.0 (recorded in 2018), while the average stood at $216125.0.
  • Per our database at Business Quant, Abeona Therapeutics' Interest & Investment Income skyrocketed by 228095.24% in 2018 and then tumbled by 9769.94% in 2021.
  • Abeona Therapeutics' Interest & Investment Income (Quarter) stood at $533000.0 in 2018, then crashed by 90.24% to $52000.0 in 2019, then dropped by 23.08% to $40000.0 in 2020, then dropped by 10.0% to $36000.0 in 2021, then fell by 16.67% to $30000.0 in 2022.
  • Its last three reported values are $30000.0 in Q2 2022, $1000.0 for Q1 2022, and $36000.0 during Q4 2021.